glp-1 injection site reactions

semaglutide, tirzepatide, obesity treatment, prescription weight loss, GLP-1 / weight-loss drugs, GLP-1 receptor agonists — P

7 Experts Expose Prescription Weight Loss Skin Risks

7 Experts Expose Prescription Weight Loss Skin Risks Prescription GLP-1 weight-loss drugs can trigger skin risks - including injection-site reactions, dry skin, rashes, and hair loss - affecting about 23% of users within the first month. These dermatologic effects stem from rapid fat loss and hormonal changes, and they can